Shapeways (SHPWQ) 10-Q 15 Nov 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Nov. 10, 2021
Document Information [Line Items]
Document Type	10-Q
Document Period End Date	Sep. 30, 2021
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-39092
Entity Registrant Name	Shapeways Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	30-02 48th Avenue
Entity Address, City or Town	Long Island City
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11101
City Area Code	646
Local Phone Number	979-9885
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		48,296,484
Entity Central Index Key	0001784851
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Tax Identification Number	87-2876494
Warrant [Member]
Document Information [Line Items]
Security Exchange Name	NYSE
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share
Trading Symbol	SHPW WS
Common Stock [Member]
Document Information [Line Items]
Security Exchange Name	NYSE
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	SHPW

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 90,108	$ 8,564
Restricted cash	143	145
Accounts receivable	1,114	185
Inventory	573	727
Promissory note due from related party	0	151
Prepaid expenses and other current assets	1,908	1,910
Total current assets	93,846	11,682
Property and equipment, net	1,090	948
Right-of-use assets, net	982	2,102
Goodwill	1,835	1,835
Security deposits	175	175
Total assets	97,928	16,742
LIABILITIES
Accounts payable	1,168	1,633
Accrued expenses and other liabilities	3,700	3,319
Current portion of long-term debt	39	8,332
Operating lease liabilities, current	631	1,222
Deferred revenue	658	753
Total current liabilities	6,196	15,259
Operating lease liabilities, net of current portion	499	1,094
Warrant Liabilities	6,777	0
Long-term debt	88	2,236
Total liabilities	13,560	18,589
Commitments and Contingencies
Shareholders' Equity
Preferred stock ($0.0001 par value; 10,000,000 shares authorized; none issued and outstanding as of September 30, 2021 and December 31, 2020, respectively)	0	0
Common stock ($0.0001 par value; 120,000,000 shares authorized; 48,296,484 and 32,170,068 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively)	5	3
Additional paid-in capital	195,121	112,994
Accumulated deficit	(110,442)	(114,567)
Accumulated other comprehensive loss	(316)	(277)
Total stockholders' equity (deficit)	84,368	(1,847)
Total liabilities and stockholders' equity (deficit)	$ 97,928	$ 16,742

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
CONSOLIDATED BALANCE SHEETS
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	120,000,000	120,000,000
Common stock, shares issued	48,296,484	32,170,068
Common stock, shares outstanding	48,296,484	32,170,068

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue, net	$ 7,716	$ 8,107	$ 25,354	$ 23,028
Cost of revenue	4,055	4,406	13,271	13,030
Gross profit	3,661	3,701	12,083	9,998
Operating expenses
Selling, general and administrative	4,366	2,461	10,513	8,075
Research and development	1,673	1,516	4,099	4,289
Amortization and depreciation	33	37	100	113
Total operating expenses	6,072	4,014	14,712	12,477
Loss from operations	(2,411)	(313)	(2,629)	(2,479)
Other income (expense)
Long-term debt forgiveness	0	0	2,000	0
Interest expense	(126)	(141)	(407)	(444)
Change in fair value of warrant liabilities	5,088	0	5,088	0
Interest Income	1	0	1	0
Other income	0	4	1	7
Loss on disposal of assets	0	0	0	(4)
Total other income (expense), net	4,963	(137)	6,683	(441)
Income (loss) before income tax benefit	2,552	(450)	4,054	(2,920)
Income tax benefit	0	0	(71)
Net income (loss)	2,552	(450)	4,125	(2,920)
Deemed dividend - Earnout Shares	(18,132)	0	(18,132)
Net loss attributable to common stockholders	$ (15,580)	$ (450)	$ (14,007)	$ (2,920)
Net income (loss) per share:
Basic	$ 0.07	$ (0.01)	$ 0.11	$ (0.08)
Diluted	0.07	(0.01)	0.11	(0.08)
Net loss per share attributable to common stockholders:
Basic	(0.41)	(0.01)	(0.38)	(0.08)
Diluted	$ (0.41)	$ (0.01)	$ (0.38)	$ (0.08)
Weighted Average Common Shares Outstanding [Abstract]
Basic	37,932,345	35,787,986	37,351,244	35,660,635
Diluted	37,932,345	35,787,986	37,351,244	35,660,635
Other comprehensive (loss) income
Foreign currency translation adjustment	$ (22)	$ 65	$ (39)	$ 32
Comprehensive loss	$ (15,602)	$ (385)	$ (14,046)	$ (2,888)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Series B1 Preferred Stock [Member]	Previously Reported [Member]	Preferred Stock	Preferred StockPreviously Reported [Member]	Preferred StockRevision of Prior Period, Adjustment [Member]	Common Stock	Common StockSeries B1 Preferred Stock [Member]	Common StockSeries D Preferred Stock [Member]	Common StockPreviously Reported [Member]	Common StockRevision of Prior Period, Adjustment [Member]	Additional Paid-in Capital	Additional Paid-in CapitalSeries B1 Preferred Stock [Member]	Additional Paid-in CapitalPreviously Reported [Member]	Additional Paid-in CapitalRevision of Prior Period, Adjustment [Member]	Accumulated Deficit	Accumulated DeficitPreviously Reported [Member]	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive LossPreviously Reported [Member]
Beginning Balance at Dec. 31, 2019	$ 431		$ 431		$ 2		$ 3			$ 2		$ 112,187		$ 112,186		$ (111,399)	$ (111,399)	$ (360)	$ (360)
Beginning Balance (in Shares) at Dec. 31, 2019				0	22,579,695		31,921,259			15,894,428
Retroactive application of reverse recapitalization						$ (2)					$ 1				$ 1
Retroactive application of reverse recapitalization (Shares)						(22,579,695)					16,026,831
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)							994
Stock-based compensation expense	171											171
Net loss	(1,435)															(1,435)
Foreign currency translation	(61)																	(61)
Ending Balance at Mar. 31, 2020	(894)			$ 0			$ 3					112,358				(112,834)		(421)
Ending Balance (in shares) at Mar. 31, 2020				0			31,922,253
Beginning Balance at Dec. 31, 2019	431		431		$ 2		$ 3			$ 2		112,187		112,186		(111,399)	(111,399)	(360)	(360)
Beginning Balance (in Shares) at Dec. 31, 2019				0	22,579,695		31,921,259			15,894,428
Net loss	(2,920)
Ending Balance at Sep. 30, 2020	(1,845)			$ 0			$ 3					112,799				(114,319)		(328)
Ending Balance (in shares) at Sep. 30, 2020				0			32,132,078
Beginning Balance at Mar. 31, 2020	(894)			$ 0			$ 3					112,358				(112,834)		(421)
Beginning Balance (in Shares) at Mar. 31, 2020				0			31,922,253
Issuance of Legacy Shapeways common stock upon exercise of stock options	47											47
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)							141,270
Stock-based compensation expense	190											190
Net loss	(1,035)															(1,035)
Foreign currency translation	28																	28
Ending Balance at Jun. 30, 2020	(1,664)			$ 0			$ 3					112,595				(113,869)		(393)
Ending Balance (in shares) at Jun. 30, 2020				0			32,063,523
Issuance of Legacy Shapeways common stock upon exercise of stock options	21											21
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)							68,555
Stock-based compensation expense	183											183
Net loss	(450)															(450)
Foreign currency translation	65																	65
Ending Balance at Sep. 30, 2020	(1,845)			$ 0			$ 3					112,799				(114,319)		(328)
Ending Balance (in shares) at Sep. 30, 2020				0			32,132,078
Beginning Balance at Dec. 31, 2020	$ (1,847)		(1,847)	$ 0	$ 2		$ 3			$ 2		112,994		112,993		(114,567)	(114,567)	(277)	(277)
Beginning Balance (in Shares) at Dec. 31, 2020	32,170,068			0	22,579,695		32,184,263			16,211,567
Retroactive application of reverse recapitalization						$ (2)					$ 1				$ 1
Retroactive application of reverse recapitalization (Shares)						(22,579,695)					15,972,696
Issuance of Legacy Shapeways common stock upon exercise of stock options	$ 16											16
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)	35,895						35,895
Stock-based compensation expense	$ 174											174
Net loss	1,708															1,708
Foreign currency translation	(9)																	(9)
Ending Balance at Mar. 31, 2021	42			$ 0			$ 3					113,184				(112,859)		(286)
Ending Balance (in shares) at Mar. 31, 2021				0			32,220,158
Beginning Balance at Dec. 31, 2020	$ (1,847)		$ (1,847)	$ 0	$ 2		$ 3			$ 2		112,994		$ 112,993		(114,567)	$ (114,567)	(277)	$ (277)
Beginning Balance (in Shares) at Dec. 31, 2020	32,170,068			0	22,579,695		32,184,263			16,211,567
Net loss	$ 4,125
Ending Balance at Sep. 30, 2021	$ 84,368			$ 0			$ 5					195,121				(110,442)		(316)
Ending Balance (in shares) at Sep. 30, 2021	48,296,484			0			48,296,484
Beginning Balance at Mar. 31, 2021	$ 42			$ 0			$ 3					113,184				(112,859)		(286)
Beginning Balance (in Shares) at Mar. 31, 2021				0			32,220,158
Issuance of Legacy Shapeways common stock upon exercise of stock options	$ 55											55
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)	63,506						63,506
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants		$ 60											$ 60
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants (shares)								19,177
Stock-based compensation expense	$ 171											171
Net loss	(135)															(135)
Foreign currency translation	(8)																	(8)
Ending Balance at Jun. 30, 2021	185			$ 0			$ 3					113,470				(112,994)		(294)
Ending Balance (in shares) at Jun. 30, 2021				0			32,302,841
Issuance of Legacy Shapeways common stock upon exercise of stock options	$ 481											481
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)	1,113,029						1,113,029
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants (shares)									89,217
Issuance of Legacy Shapeways common stock upon conversion of convertible notes	$ 5,913											5,913
Issuance of Legacy Shapeways common stock upon conversion of convertible notes (shares)							1,406,741
Issuance of Legacy Shapeways common stock upon exercise of warrants (shares)							212,234
Repurchase of Legacy Shapeways common stock	(152)											(152)
Repurchase of Legacy Shapeways common stock (shares)							(19,226)
Effect of Merger and recapitalization, net of redemptions and issuance costs	10,036						$ 1					10,035
Effect of Merger and recapitalization, net of redemptions and issuance costs (shares)							5,691,648
Issuance of common stock pursuant to PIPE financing, net of issuance costs	64,937						$ 1					64,936
Issuance of common stock pursuant to PIPE financing, net of issuance costs (shares)							7,500,000
Stock-based compensation expense	438											438
Net loss	2,552															2,552
Foreign currency translation	(22)																	(22)
Ending Balance at Sep. 30, 2021	$ 84,368			$ 0			$ 5					$ 195,121				$ (110,442)		$ (316)
Ending Balance (in shares) at Sep. 30, 2021	48,296,484			0			48,296,484

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash Flows from Operating Activities:
Net income (loss)	$ 4,125	$ (2,920)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	424	362
Loss on disposal of assets	0	4
Stock-based compensation expense	783	544
Non-cash lease expense	696	1,586
Non-cash debt forgiveness	(2,000)	0
Change in fair value of warrant liabilities	(5,088)	0
Change in operating assets and liabilities:
Accounts receivable	(924)	(763)
Inventory	173	(102)
Prepaid expenses and other assets	83	337
Interest on promissory note due from related party	0	50
Accounts payable	(512)	(775)
Accrued expenses and other liabilities	853	713
Lease liabilities	(762)	(1,674)
Deferred revenue	(101)	67
Deferred rent	0	(283)
Net cash used in operating activities	(2,250)	(2,854)
Cash flows from investing activities:
Purchases of property and equipment	(125)	(23)
Net cash used in investing activities	(125)	(23)
Cash flows from financing activities:
Principal payments on capital leases	0	(18)
Proceeds from issuance of common stock	552	68
Proceeds received from exercise of preferred stock warrants	60	0
Effect of Merger, net of transaction costs	86,792
Repayments of loans payable	(3,459)	(851)
Proceeds from loans payable	0	1,983
Net cash provided by financing activities	83,945	1,182
Net change in cash and cash equivalents and restricted cash	81,570	(1,695)
Effect of change in foreign currency exchange rates on cash and cash equivalents and restricted cash	(28)	8
Cash and cash equivalents and restricted cash at beginning of period	8,709	9,605
Cash and cash equivalents and restricted cash at end of period	90,251	7,918
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest	88	145
Accrued acquisition of property and equipment	441	0
Issuance of Legacy Shapeways common stock upon conversion of convertible notes	5,913	0
Repurchase of Legacy Shapeways common stock	$ (152)	$ 0

Organization

Organization	9 Months Ended
	Sep. 30, 2021
Organization
Organization	Note 1. Organization On September 29, 2021 (the “Closing” or the “Closing Date”), Galileo Acquisition Corp., a Cayman Islands exempted company (“Galileo” and after the Domestication (as defined below) “Shapeways”), a publicly-traded special purpose acquisition company, consummated the transactions described in the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) dated April 28, 2021, by and among Galileo Founders Holdings, L.P. (the “Sponsor”), Galileo Acquisition Corp., Galileo Acquisition Holdings, Inc., a Delaware corporation and wholly-owned subsidiary of Galileo (“Merger Sub”), and Shapeways, Inc., a Delaware corporation (“Legacy Shapeways”), Further, on the Closing Date, as contemplated by the Merger Agreement, Galileo filed a notice of deregistration with the Cayman Islands Registrar of Companies, together with the necessary accompanying documents, and filed a certificate of incorporation and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which Galileo was domesticated and continued as a Delaware corporation (the “Domestication” and, together with the Merger, the “Business Combination”), changing its name to “Shapeways Holdings, Inc.” (the “Company” and/or “Shapeways”). Shapeways is a leader in the large and fast-growing digital manufacturing industry combining high quality, flexible on-demand manufacturing powered by purpose-built proprietary software which enables customers to rapidly transform digital designs into physical products, globally. Shapeways makes industrial-grade additive manufacturing accessible by fully digitizing the end-to-end manufacturing process , and by providing a broad range of solutions utilizing 11 additive manufacturing technologies and more than 90 materials and finishes, with the ability to easily scale new innovation. Shapeways has delivered over 21 million parts to 1 million customers in over 160 countries.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information as defined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and in accordance with the instruction to Form 10-Q S-X The Business Combination has been accounted for as a reverse recapitalization, in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, Galileo has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination has been treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo are stated at historical cost, with no goodwill or other intangible assets recorded. There has been no accounting effect or change in the carrying amount of the assets and liabilities as a result of the Business Combination. Legacy Shapeways has been treated as the accounting acquirer based on evaluation of the following facts and circumstances with regard to the Company as of the Closing: • Legacy Shapeways’ directors represented the majority of the new board of directors of the Company; • The executive officers and senior management of Legacy Shapeways are the executive officers and senior management of the Company; • The assets of Legacy Shapeways represent a significant majority of the assets of the Company (excluding cash formerly held in the Galileo trust account); and • The business of the Company will be the continued business of Legacy Shapeways. The business of the Company will continue to focus on Legacy Shapeways’ core offerings related to the facilitation of the sale, design and manufacturing of 3D printed items. The consolidated assets, liabilities and results of operations prior to the Reverse Recapitalization are those of Legacy Shapeways. The shares and corresponding capital amounts and losses per share, prior to the Merger, have been retroactively adjusted based on shares reflecting the conversion ratio (as defined below) established in the Merger. Use of Estimates The preparation of the Company’s unaudited In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) Functional Currency The local currency is the functional currency for Shapeways BV’s (a wholly Cash, Cash Equivalents and Cash includes cash on hand and demand deposits. The Company maintains its deposits at high quality financial institutions and monitors the credit ratings of those institutions. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. While cash held by financial institutions may at times exceed federally insured limits The reconciliation of cash, cash equivalents and restricted cash reported within the applicable consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statements of cash flows is as follows: September 30, 2021 December 31, 2020 Cash and cash equivalents $ 90,108 $ 8,564 Restricted cash 143 145 $ 90,251 $ 8,709 Accounts Receivable Accounts receivables are recorded at the invoiced amount and are generally unsecured as they are uncollateralized. The Company provides an allowance for doubtful accounts to reduce receivables to their estimated net realizable value. Judgement is exercised in establishing allowances and estimates are based on the customers’ payment history and liquidity. Any amounts that were previously recognized as revenue and subsequently determined to be uncollectible are charged to bad debt expense included in selling, general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive loss. Given the nature and historical collectability of the Company’s accounts receivable, an allowance for doubtful accounts was not deemed necessary at September 30, 2021 and December 31, 2020. Inventory Inventory consists of raw materials, work in progress and finished goods at the Company’s distribution center. Raw materials are stated at the lower of cost or net realizable value, determined by the first-in-first-out Property and Equipment, net Property and equipment are stated at cost, less accumulated depreciation. Maintenance and repairs are charged to expense when incurred. Additions and improvements that extend the economic useful life of the asset are capitalized and depreciated over the remaining useful lives of the assets. The cost and accumulated depreciation of assets sold or retired are removed from the respective accounts, and any resulting gain or loss is reflected in current earnings. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020. Depreciation is recognized using the straight-line method in amounts considered to be sufficient to allocate the cost of the assets to operations over the estimated useful lives or lease terms, as follows: Asset Category Depreciable Life Machinery and equipment 5 years Computers and IT equipment 3 years Furniture and fixtures 7 years Leasehold improvements * * ** Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life of the asset. Long-Lived Assets, Including Definite-Lived Intangible Assets Intangible assets, which consist of technology, customer relationships, and trademarks, are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from three to eight years. The Company periodically reviews the estimated useful lives of intangible assets and adjusts when events indicate that a shorter life is appropriate. In accordance with authoritative accounting guidance, capitalization of costs to develop software begin when preliminary development efforts are successfully and completed. Costs related to the design or maintenance of internal-use Long-lived assets, other than goodwill and other indefinite-lived intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets. Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant underperformance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations and comprehensive loss. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020. Goodwill Goodwill, which represents the excess of purchase prices over the fair value of net assets acquired, is carried at cost. Goodwill is not amortized; rather, it is subject to a periodic assessment for impairment by applying a fair value-based test. Goodwill is evaluated for impairment on an annual basis at a level of reporting referred to as the reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. Under ASC 350, Intangibles - Goodwill and Other the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test is performed. Impairment tests are performed, at a minimum, in the fourth quarter of each year. Management uses the future discounted cash flows valuation approach to determine the fair value of reporting units and determines whether the fair value of reporting units exceeded its carrying amounts. If the fair value exceeds the carrying amount, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, then an impairment charge is recognized for the difference. The impairment review requires management to make judgments in determining various assumptions with respect to revenues, operating margins, growth rates and discount rates. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company’s financial condition and results of operations. There was no impairment of goodwill as of September 30, 2021 or December 31, 2020 Fair Value Measurements The Company applies ASC 820, Fair Value Measurement The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below: Level 1 - Level 2 - Level 3 - Revenue Recognition Revenue is derived from two primary sources: a) products and services and b) software. The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the products or services it transfers to the customer. These contracts have different terms based on the scope, performance obligations, and complexity of the project, which often requires us to make judgments and estimates in recognizing revenues. Performance obligations are satisfied both at a point Leases The Company’s lease arrangements relate primarily to office and manufacturing space, and equipment. The Company’s leases generally have initial terms ranging from 5 to 10 years and may include renewal options and rent escalation clauses. The Company is typically required to make fixed minimum rent payments relating to its right to use an underlying leased asset. Additionally, the Company’s leases do not contain significantly restrictive covenants or residual value guarantees. The Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented as right-of-use arrangements. ROU assets represent the Company’s right to use an underlying asset, and lease liabilities represent the Company’s obligation for lease payments in exchange for the ability to use the asset for the duration of the lease term. The Company does not recognize short term leases that have a term of twelve months or less as ROU assets or lease liabilities. The Company’s short-term leases are not material and do not have a material impact on its ROU assets or lease liabilities. ROU assets and lease liabilities The Company has lease agreements which contain both lease and non-lease non-lease Stock-based Compensation The Company recognizes stock-based compensation expense for all options and other arrangements within the scope of ASC 718, Stock Compensation Public and Private Common Stock Warrant Liabilities As part of Galileo’s initial public offering, Galileo issued to third party investors 13,800,000 units, consisting of one ordinary share of Galileo and one warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of C S The Private Warrants are identical The Company evaluated the Public and Private Warrants under ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity 815-40”), Research and Development Costs Research and development expenses consist primarily of allocated personnel costs, fees paid to consultants and outside service providers, and allocations for rent and overhead. Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received. For the three months ended September 30, 2021 and 2020, research and development costs were $1,673 and $1,516, respectively. For the nine months ended September 30, 2021 and 2020, research and development costs were $4,099 and $4,289, respectively. Advertising Advertising costs are expensed as incurred. For the three months ended September 30, 2021 and 2020, advertising costs were $568 and $123, respectively. For the nine months ended September 30, 2021 and 2020, advertising costs were $1,008 and $353, respectively, which are included in selling, general and administrative expense on the condensed Income Taxes The Company files income tax returns in the The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on income tax returns it files if such tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. These tax benefits are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. Although the Company believes that i t In applying the estimated annual effective tax rate approach prescribed under ASC 740, Income Taxes, (1.78)% for the nine months ended September 30, 2021 differs from the applicable statutory tax rate primarily due to the fact that income recognized for the forgiveness of loans granted under the PPP loan program and changes in the fair value of warrant liabilities are not taxable under current U.S. tax law. Income (Loss) per Share In accordance with the provisions of ASC 260, Earnings Per Share if-converted The following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Common stock warrants 18,410,000 — 18,410,000 — Earnout Shares 3,510,405 — 3,510,405 — Included in income (loss) per common share are options Segment Information The Company has determined that it operates and reports in one segment, which focuses on providing additive manufacturing services to customers. The Company’s operating segment is reported in a manner consistent with the internal reporting provided to the chief operating decision maker (“CODM”). The Company’s CODM has been identified as its Chief Executive Officer. Recent Accounting Pronouncements Accounting Pronouncements Recently Adopted In January 2017, the FASB issued Accounting Standard Update (“ASU”) No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, 2017-04 In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes No. 2019-12 No. 2019-12 No. 2019-12 2019-12 In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) 815-40): 470-20, 2020-06 In August 2018, the FASB issued ASU No. 2018-15, Intangibles – Goodwill and Other – Internal-Use 350-40): internal-use internal-use Accounting Pronouncements Not Yet Adopted In June 2016, the FASB issued ASU No. 2016-13, Accounting for Credit Losses (Topic 326), which requires the use of an “expected loss” model on certain types of financial instruments. The standard also amends the impairment model for available-for-sale debt securities and requires estimated credit losses to be recorded as allowances instead of reductions to amortized cost of the securities. Update No. 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those annual periods. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact the standard will have on its condensed consolidated financial statements.

Reverse Recapitalization

Reverse Recapitalization	9 Months Ended
	Sep. 30, 2021
Reverse Recapitalization [Abstract]
Reverse Recapitalization	Note 3. Reverse Recapitalization As discussed in Note 1, on September 29, 2021, Galileo closed the Business Combination with Shapeways, Inc., as a result of which Legacy Shapeways became a wholly-owned subsidiary of Galileo. While Galileo was the legal acquirer of Legacy Shapeways in the business combination, for accounting purposes, the Business Combination is treated as a Reverse Recapitalization, whereby Legacy Shapeways is deemed to be the accounting acquirer, and the historical financial statements of Legacy Shapeways became the historical financial statements of Galileo upon the closing of the Business Combination. Under this method of accounting, Galileo was treated as the “acquired” company and Legacy Shapeways is treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo were stated at historical cost, with no goodwill or other intangible assets recorded. At the closing of the Business Combination, (1) all outstanding shares of Legacy Shapeways’ preferred stock (including shares of Legacy Shapeways’ preferred stock issuable upon conversion of Legacy Shapeways’ convertible notes outstanding as of the Closing) and Shapeways’ common stock were converted into an aggregate of 35,104,836 shares of Common Stock of the Company, par value $0.0001 per share, representing aggregate consideration value equal to $406,000 (the “Merger Consideration”), 3,510,405 shares of which are subject to the Earnout Terms (as defined below, and such shares, the “Earnout Shares”), (2) options to purchase Legacy Shapeways’ common stock (whether vested or unvested, exercisable or unexercisable) issued pursuant to the Legacy Shapeways 2010 Stock Plan, as amended (the “2010 Stock Plan”), and outstanding immediately prior to the Closing were assumed and converted into (a) options to purchase an aggregate of shares of Common Stock under the Equity Incentive Plan (the “Incentive Plan”) and (b) in the case of in-the-money options held by individuals who were service providers as of the Closing Date, an aggregate of restricted stock units denominated in a number of shares of Common Stock (“Earnout RSUs”) granted under the Incentive Plan, which Earnout RSUs are subject to the earnout vesting and forfeiture conditions described in the Merger Agreement, all warrants to purchase Legacy Shapeways’ common stock and Shapeways’ preferred stock outstanding immediately prior to the Closing were exercised in full and converted into shares of Legacy Shapeways preferred stock or Legacy Shapeways common stock, as applicable, in accordance with their terms, and each such share of Legacy Shapeways preferred stock and Legacy Shapeways common stock issued upon the exercise of such warrants was converted into an aggregate of shares of Common Stock (for the avoidance of doubt, such shares of Common Stock are included in the aggregate shares of Common Stock described in clause above) and any Legacy Shapeways non-plan options outstanding immediately prior to Closing were cancelled without payment in accordance with the terms described in the Merger Agreement. At the Closing, there were 3,510,405 shares of Common Stock issued as part of the Merger Consideration (the “Stockholder Merger Consideration” and/or “Earnout Shares”) subject to vesting and forfeiture conditions (the “Earnout Terms”) based upon the volume-weighted average trading price of Common Stock reaching targets of $14.00 and $16.00, respectively (with 50% released at each target) for a period of 30 consecutive trading days during the three-year period after the Closing, with the portion of such shares that would otherwise be deliverable to Shapeways Stockholders at the Closing being withheld and deposited into escrow. A pro rata portion of the Stockholder Merger Consideration earnout has also been allocated to Legacy Shapeways options and warrants that, as of the Closing, have been exchanged for options and warrants (as applicable) exercisable for shares of Common Stock (as described below). Legacy Shapeways options issued pursuant to Legacy Shapeways’ 2010 Stock Plan that were not exercised prior to the Closing have been assumed by the Company and converted, subject to certain adjustments that are described in the Merger Agreement, into options exercisable for shares of Common Stock and, in the case of in-the-money Simultaneously with the execution of the Business Combination, Galileo entered into subscription agreements (collectively, the “Subscription Agreements”) pursuant to which certain investors agreed to purchase an aggregate of 7,500,000 shares of Common Stock for a purchase price of $10.00 per share and $75,000,000 in the aggregate (the “PIPE Investment”). At the Closing, the Company consummated the PIPE Investment. The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of cash flows for the nine months ended September 30, 2021: Recapitalization Cash - Galileo trust and cash, net of redemption $ 28,115 Cash - PIPE Investment, net of transaction costs 75,000 Less: transaction costs and advisory fees allocated to equity (16,323 ) Effect of Merger, net of redemption, transaction costs and advisory costs $ 86,792 The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of changes in stockholders’ equity (deficit) for the three and nine months ended September 30, 2021: Recapitalization Cash - Galileo trust and cash, net of redemption $ 28,115 Non-cash 46 Less: fair value of Private and Sponsor Warrant liabilities (11,865 ) Less: transaction costs and advisory fees allocated to equity (6,260 ) Effect of Merger, net of redemption, transaction costs and advisory costs $ 10,036 The following table details the number of shares of Common Stock issued immediately following the consummation of the Business Combination: Number of Shares Common stock, outstanding prior to Business Combination 13,800,000 Less: redemption of Galileo shares (11,018,352 ) Common stock of Galileo 2,781,648 Galileo founder and representative shares, net of forfeited shares 2,910,000 Shares issued in PIPE Investment 7,500,000 Merger and PIPE Investment - common stock 13,191,648 Legacy Shapeways shares - common stock (1) 35,104,836 Total shares of common stock immediately after Business Combination 48,296,484 (1) Includes 3,510,405 Earnout Shares

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2021
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Note 4. Revenue Recognition Under ASC 606, revenue is recognized throughout the life of the executed agreement. The Company measures revenue based on consideration specified in a contract with a customer. Furthermore, the Company recognizes revenue when a performance obligation is satisfied by transferring control of the product or service to the customer which could occur over time or at a point in time. A performance obligation is a promise in a contract to transfer a distinct service to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation. Customers typically receive the benefit of the Company’s services as (or when) they are performed. Substantially all customer contracts provide that compensation is received for services performed to date. Taxes assessed by a governmental au thority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer, are excluded from revenue. Nature of Products and Services The following is a description of the Company’s products services Direct sales The Company provides customers with an additive manufacturing service, allowing for the customer to select the specifications of the model which they wish to have printed. Shapeways prints the 3D model and ships the product directly to the customer. The Company recognizes the sale of shop owner products through their e-commerce e-commerce Marketplace sales The Company provides a platform for shop owners to sell their products to customers through Shapeways’ marketplace website. Shapeways receives a 3.5% markup fee from the shop owner upon the sale of any products through the marketplace. The Company handles the financial transaction, manufacturing, distribution and customer service on behalf of the shop owners. The Company is responsible for billing the customer in this arrangement and transmitting the applicable fees to the shop owner. The Company assessed whether it is responsible for providing the actual product or service as a principal, or for arranging for the product or service to be provided by the third party as an agent. Judgment is applied to determine whether the Company is the principal or the agent by evaluating whether it has control of the product or service prior to it being transferred to the customer. The principal versus agent assessment is performed at the performance obligation level. Indicators that the Company has considered include whether it has the primary responsibility for fulfilling the promise to provide the specified product or service to the customer and whether it has inventory risk prior to transferring the product or service to the customer. The Company has the responsibility to fulfill the promise to provide the specific good or service on behalf of the shop owners to the customer. In addition, the Company has inventory risk before the specific good or service is transferred to a customer. As such, the Company is deemed the principal and shall recognize revenue on a gross basis for the price it charges to the shop owner for each product or service. The Company recognizes the sale of 3D products to customers at a point in time, specifically upon shipping the goods to the customer (FOB Origin) given the transfer of significant risks and rewards of ownership at that point in time. Contracts involving the manufacturing and delivery of 3D printed products to customers do not include other performance obligations. As such, allocation of the transaction price was not necessary as the entire contract price is attributed to the sole performance obligation identified. Software revenue In 2020, Shapeways launched their software under the brand of “Powered by Shapeways” to a limited set of design customers to gain feedback on product market fit. The software enables other manufacturers to leverage Shapeways’ existing end-to-end manufacturing software to scale their businesses and shift to digital manufacturing. For each of the performance obligations classified as software revenue, the performance obligations are satisfied evenly over the term of the contract. For contracts including performance obligations classified as software revenue, the Company identified that each performance obligation has an explicitly stated standalone selling price. As such, allocation is not necessary as the prices included in the contract are attributed to each separate performance obligation. The following table presents our revenues disaggregated by revenue discipline: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Major products/service lines: Direct sales $ 5,985 $ 5,994 $ 19,068 $ 16,827 Marketplace sales 1,663 2,091 6,062 6,060 Software 68 22 224 141 Total revenue $ 7,716 $ 8,107 $ 25,354 $ 23,028 Timing of revenue recognition: Products transferred at a point in time $ 1,663 $ 2,091 $ 6,062 $ 6,060 Products and services transferred over time 6,053 6,016 19,292 16,968 Total revenue $ 7,716 $ 8,107 $ 25,354 $ 23,028 Deferred Revenue The Company records deferred revenue when cash payments are received in advance of performance. Deferred revenue activity consisted of the following for the nine months ended September 30, 2021: Deferred Revenue Balance at January 1, 2021 $ 753 Deferred revenue recognized during period (25,354 ) Additions to deferred revenue during period 25,259 Balance at September 30, 2021 $ 658 The Company expects to satisfy its remaining performance obligations within the next twelve months. The $753 of deferred revenue as of January 1, 2021 was recognized during the nine months ended September 30, 2021. The opening balance of accounts receivable as of January 1, 2020 was $151. Practical Expedients and Exemptions We apply the practical expedient related to incremental costs of obtaining a contract. Although certain of our commission costs qualify for capitalization under ASC 340-40, practical expedient

Inventory

Inventory	9 Months Ended
	Sep. 30, 2021
Inventory Disclosure [Abstract]
Inventory	Note 5. Inventory Components of inventory consisted of the following: September 30, December 31, Raw materials $ 418 $ 521 Work-in-process 40 36 Finished goods 115 170 Total $ 573 $ 727

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	9 Months Ended
	Sep. 30, 2021
Prepaid Expense and Other Assets, Current [Abstract]
Prepaid Expenses and Other Current Assets	Note 6. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following: September 30, December 31, Prepaid expenses $ 698 $ 646 Security deposits 259 259 VAT receivable 950 975 Other current assets 1 30 Total $ 1,908 $ 1,910

Property and Equipment, net

Property and Equipment, net	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment, net	Note 7. Property and Equipment, net Property and equipment consisted of the following: September 30, December 31, Machinery and equipment $ 1,388 $ 1,430 Computers and IT equipment 5,631 5,193 Furniture and fixtures 49 50 Leasehold improvements 2,477 2,520 9,545 9,193 Less: Accumulated depreciation (8,455 ) (8,245 ) Property and equipment, net $ 1,090 $ 948 For the three months ended September 30, 2021 and 2020, depreciation expense totaled $146 and $115, respectively. For the nine months ended September 30, 2021 and 2020, depreciation expense totaled $424 and $362, respectively. Of these amounts, depreciation charged to cost of revenue was $113 and $78 for the three months ended September 30, 2021 and 2020, respectively, and $324 and $249 for the nine months ended September 30, 2021 and 2020, respectively.

Accrued Expenses and Other Liab

Accrued Expenses and Other Liabilities	9 Months Ended
	Sep. 30, 2021
Accrued Expenses And Other Liabilities Current [Abstract]
Accrued Expenses and Other Liabilities	Note 8. Accrued Expenses and Other Liabilities Accrued expenses consisted of the following: September 30, December 31, Accrued selling expenses $ 712 $ 947 Accrued compensation 757 876 Interest payable — 612 Taxes payable 306 477 Accrued transaction costs 450 — Accrued acquisition of property and equipment 441 — Shapeways credits 300 313 Other 734 94 Total $ 3,700 $ 3,319

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 9. Commitments and Contingencies Leases During the three a The table below presents certain information related to the Company’s lease costs: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Operating lease expense $ 144 $ 482 $ 696 $ 1,585 Finance lease expense — — — 16 Interest expense on finance lease liabilities — — — 1 Short-term lease expense — — — 14 Total lease cost $ 144 $ 482 $ 696 $ 1,616 Right of use assets and lease liabilities for operating leases were recorded September 30, December 31, Assets: Right-of-use $ 982 $ 2,102 Total lease assets $ 982 $ 2,102 Liabilities: Current liabilities: Operating lease liabilities, current $ 631 $ 1,222 Non-current Operating lease liabilities, net of current portion 499 $ 1,094 Total lease liability $ 1,130 $ 2,316 The Company’s lease agreements do not state an implicit borrowing rate; therefore, an internal incremental borrowing rate was determined based on information available at the lease commencement date for the purposes of determining the present value of lease payments. The incremental borrowing rate reflects the cost to borrow on a securitized basis in each market. The weighted-average remaining lease term for operating leases was 2.05 years and the weighted-average incremental borrowing rate was 5.34% as of September 30, 2021. Supplemental cash flow information related to the Company’s leases was as follows: Nine Months Ended 2021 2020 Operating cash flows from operating leases $ 762 $ 1,754 Operating cash flows from finance leases — 1 Financing cash flows from finance leases — 18 Lease liabilities arising from obtaining right-of-use — 4,025 As of September 30, 2021, future minimum Rest of 2021 $ 167 2022 680 2023 214 2024 132 2025 1 Total minimum lease payments 1,194 Less effects of discounting (64 ) Present value of future minimum lease payments $ 1,130 Desktop Metal On March 26, 2021, the Company entered into a non-binding Memorandum of Understanding (“MOU”) with Desktop Metal, pursuant to which Desktop Metal agreed to invest $20.0 million in the PIPE Investment. Upon consummation of this investment, the Company became obligated to purchase $20.0 million of equipment, materials and services from Desktop Metal. In conjunction with these obligations, the Company and Desktop Metal agreed to develop a strategic partnership. In November 2021, the Company paid $3.5 million to Desktop Metal for equipment received, and has a commitment to place purchase orders for another $16.5 million of equipment and materials under the MOU by or before December 3 1, 2021. Legal Proceedings The Company is involved in various legal proceedings which arise from time to time in the normal course of business. While the results of such matters generally cannot be predicted with certainty, management does not expect any such matters to have a material adverse effect on the Company’s condensed consolidated financial position or results of operations as of September 30, 2021 and December 31, 2020, and for the three and nine months ended September 30, 2021 and 2020.

Borrowing Arrangements

Borrowing Arrangements	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Borrowing Arrangements	Note 10. Borrowing Arrangements The Company’s outstanding debt obligations consisted of the following: September 30, December 31, Dutch Landlord Loan $ 127 $ 163 Term Loan — 3,423 Convertible Promissory Notes — 5,000 PPP Loan — 1,982 127 10,568 Less: current portion (39 ) (8,332 ) Long-term debt $ 88 $ 2,236 Dutch Landlord Loan On May 12 , 2014, the Company entered into a loan agreement with its landlord at the Eindhoven factory (the “Dutch Landlord Loan”) to advance €242 (equivalent to $280 and $297 in total at September 30, 2021 and December 31, 2020, respectively) to finance leasehold improvements . For the three months ended September 30, 2021 and 2020, interest expense totaled $5, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $14, respectively. Term Loan On October 29, 2018, the Company entered into a loan and security agreement (the “Term Loan”) for the principal sum of $5,000 with a maturity date of October 29, 2022. The Term Loan requires interest-only payments until October 29, 2019, followed by monthly payments of principal and interest. Interest is payable at a rate equal to the prime rate, plus 0.25% per annum. At the Closing of the Business Combination, the Company repaid and terminated the Term Loan in full. As of December 31, 2020, the interest rate was 3.50%. In connection with the Term Loan, the bank is due a $75 fee in the event of a liquidity event valuing the Company above a certain threshold. For the three months ended September 30, 2021 and 2020, interest expense totaled $12 and $36, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $66 and $129, respectively. Convertible Promissory Notes On June 19, 2019, the Company entered into note purchase agreements (the “Convertible Promissory Notes”) with certain stockholders of the Company for the aggregate principal sum of $5,000. The Convertible Promissory Notes bear interest at a rate of 8% per annum with all principal and interest due on or before the earlier of (i) December 19, 2020; and (ii) the closing of a Qualified Equity Financing, as defined below. The Convertible Promissory Notes are automatically converted into conversion shares upon the closing of a Qualified Equity Financing. Qualified Equity Financing is defined as the next sale by the Company of preferred stock following the date of the Convertible Promissory Notes on or prior to the maturity date with the principal purpose of raising capital. In the event there is a non-Qualified Non-Qualified On December 14, 2020, the Company executed an amendment to the Convertible Promissory Notes that extended the maturity date to August 10, 2021. All other relevant terms and conditions of the Convertible Promissory Notes remain binding. Immediately prior to the completion of the Business Combination, the Convertible Promissory Notes in the aggregate principal amount of $5,000 were converted into shares of common stock of Legacy Shapeways (1,189,558 shares of Common Stock post Business Combination), and the related unpaid and accrued interest totaling $ were shares of common stock of Legacy Shapeways (217,183 shares of Common Stock post Business Combination). For the three months ended September 30, 2021 and 2020, interest expense totaled $109 and $100, respectively. For the nine months ended September 30, 2021 and 2020, interest expense totaled $309 and $300, respectively. Paycheck Protection Program Loan On May 4, 2020, the Company received an unsecured loan of $1,982 under the Paycheck Protection Program (the “PPP Loan”). The Paycheck Protection Program (or “PPP”) was established under the recently enacted CARES Act and is administered by the U.S. Small Business Administration (“SBA”). On May 4, 2020, the Company entered into a promissory note with Pacific Western Bank evidencing the unsecured PPP Loan. The PPP Loan has a maturity date of May 4, 2022 and accrues interest at an annual rate of 1.00%. To the extent the loan amount is not forgiven under the PPP, the Company is obligated to make monthly payments of principal and interest, beginning six months from the date of the note, until the maturity date. In October 2020, the PPP Flexibility Act of 2020 extended the deferral period for borrower payments on all PPP loans from six months to ten months. Interest expense totaled $18 for the nine months ended September 30, 2021. There was no interest expense incurred for the nine months ended September 30, 2020. The CARES Act and the PPP provide a mechanism for forgiveness of up to the full amount borrowed. Under the PPP, the Company may apply for and be granted forgiveness for all or part of the PPP Loan. The amount of the loan proceeds eligible for forgiveness is based on a formula that takes into account a number of factors, including the amount of loan proceeds used by the Company during the eight-week period after the loan origination for certain purposes including payroll costs, and certain rent payments, mortgage payments, and utility payments, provided that at least 75% of the loan amount is used for eligible payroll costs. Subject to the other requirements and limitations on loan forgiveness, only loan proceeds spent on payroll and other eligible costs during the covered eight-week period will qualify for forgiveness. As of September 30, 2021, the full principal and interest amount of $2,000 of the PPP Loan was forgiven and recorded in other income on the condensed consolidated statement of operations and comprehensive loss. Although the PPP Loan has been forgiven as of September 30, 2021, the Company intends to repay the PPP Loan in its entirety during the fourth quarter of 2021 and will reverse the previously recognized gain on debt forgiveness when repaid.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Stockholders' Equity (Deficit)	Note 11. Stockholders’ Equity (Deficit) The condensed consolidated statements of changes in stockholders’ equity (deficit) reflects the Business Combination as defined in Note 1 as of September 29, 2021. As Legacy Shapeways was deemed the accounting acquirer in the Business Combination with Galileo, all periods prior to the consummation date reflect the balances and activity of Legacy Shapeways. The balances as of January 1, 2021 and 2020 from the consolidated financial statements of Legacy Shapeways as of that date, share activity (convertible preferred stock, common stock, additional paid in capital, accumulated deficit, and accumulated other comprehensive loss) and per share amounts were retroactively adjusted, where applicable, using the recapitalization conversion ratio of 0.8293 (the “Conversion Ratio”). Common Stock Upon closing of the Business Combination, pursuant to the terms of the Certificate of Incorporation, the Company authorized 120,000,000 shares of C S C S The Company has issued and outstanding 48,296,484 shares of C S Legacy Shapeways Common Stock Warrants On December 18, 2013, in connection with executing a loan agreement, the Company issued warrants to purchase 40,000 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.25 per share and had an expiration date of December 18, 2023. On February 3, 2014, in connection with executing a lease agreement, the Company issued warrants to purchase 248,000 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.25 per share and expired upon the latest to occur i) seven years from the original issuance date or ii) five years from the effective date of an initial public offering. On April 22, 2015, in connection to an amended loan agreement, the Company issued warrants to purchase 13,750 shares of Legacy Shapeways common stock. The warrants had an exercise price of $1.70 per share and had an expiration date of April 22, 2025. Immediately prior to the completion of the Business Combination, all outstanding Legacy Shapeways common stock warrants were exercised into an aggregate of 255,917 shares of Legacy Shapeways common stock ( 212,234 Legacy Shapeways Convertible Preferred Stock Immediately prior to the completion of the Business Combination, all outstanding shares of the Legacy Shapeways Series A-1, A-2, B-1, Legacy Shapeways Preferred Stock Warrants On March 8, 2013, the Company issued warrants to purchase a total of 23,125 shares of Series B-1 B-1 On June 30, 2017, in connection with executing a loan agreement, the Company issued warrants to purchase a total of 57,051 shares of Series D preferred stock of Legacy Shapeways. The warrants had an exercise price of $5.2584 per share and were exercisable for ten years from the date of grant. Immediately prior to the completion of the Business Combination, the 57,051 warrants were exercised for 107,580 shares of Legacy Shapeways common stock. Public Warrants Prior to the Merger, the Company had outstanding 13,800,000 Public Warrants. Each Public Warrant entitles the holder to purchase one share of C S The Company may redeem the Public Warrants as follows: in whole and not in part; at a price of $0.01 per warrant; at any time while the Public Warrants are exercisable, upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder; if, and only if, the reported last sale price of the Company’s ordinary shares equals or exceeds $18.00 per share, for any 20 trading days within a 30-trading 30-day As of September 30, 2021, there we Public Warrants outstanding.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Note 12. Stock-Based Compensation 2010 Stock Plan Prior to the Business Combination, Legacy Shapeways maintained its 2010 Stock Plan (the “2010 Plan”), under which Legacy Shapeways granted statutory and non-statutory In connection with the Business Combination, each Legacy Shapeways stock option that was outstanding immediately prior to Closing, whether vested or unvested, was converted into an option to acquire a number of shares of common stock (each such option, an “Exchanged Option”) equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Shapeways common stock subject to such Legacy Shapeways option immediately prior to the Business Combination and (ii) 90% of the Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Shapeways option immediately prior to the consummation of the Business Combination, divided by (B) 90% of the Conversion Ratio. Except as specifically provided in the Business Combination Agreement, following the Business Combination, each Exchanged Option will continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Legacy Shapeways option immediately prior to the consummation of the Business Combination. All stock option activity was retroactively restated to reflect the Exchanged Options. In addition, as discussed in Note 3, each holder of an in-the-money of the Conversion C S If the service of the holder of an Earnout RSU terminates before the RSU Performance Milestones have been satisfied, then the portion of the Earnout RSUs for which the service-based vesting conditions has been satisfied (taking into account any acceleration provisions) shall remain outstanding and eligible to vest upon achievement of the applicable RSU Performance Milestone. Any Earnout RSUs for which the service-based vested conditions has not been satisfied as of such termination of service (taking into account any acceleration provisions) shall be forfeited and cancelled without payment. If any RSU Performance Milestone fails to be satisfied by the end of the Earnout Period, then the Earnout RSUs corresponding to such RSU Performance Milestone shall be forfeited and cancelled without payment as of the end of the Earnout Period. Upon the Closing of the Business Combination, the outstanding and unexercised Legacy Shapeways options became options to purchase an aggregate of 4,901,207 shares of the Company’s Common Stock under the 2010 Plan at an average exercise price of $0.62 per share. 2021 Equity Incentive Plan Upon non-employee shares of C S shares have been awarded and shares remain available for issuance under the 2021 Plan. Option Awards The Company accounts for share-based payments pursuant to ASC 718, Stock Compensation The fair value of stock options under the Black-Scholes model requires management to make assumptions regarding projected employee stock option exercise behaviors, risk-free interest rates, volatility of the Company’s stock price and expected dividends. The Company generally recognizes stock compensation expense on the grant date and over the period of vesting or period that services will be provided. The assumptions used to estimate the fair value of stock options granted during the periods presented were as follows: Three and Nine Months Ended 2021 2020 Strike price $ 0.17 $ 0.37 Expected term (in years) 5.55 - 6.05 5.00 - 6.04 Expected volatility 57.09% - 57.81 % 49.15% - 52.41 % Risk-free interest rate 0.50% - 0.57 % 0.37% - 1.46 % Dividend yield — — The following table summarizes the Company’s stock option plan and the activity: Shares Weighted Weighted Outstanding at January 1, 2021 (as previously reported) 8,247,340 $ 0.44 6.72 Retroactive application of reverse recapitalization (1,967,440 ) — — Outstanding as of January 1, 2021, effect of Merger 6,279,900 $ 0.58 6.64 Granted 29,420 0.36 9.82 Forfeited (145,878 ) 0.43 — Exercised (35,895 ) 0.43 — Outstanding at March 31, 2021 6,127,547 $ 0.58 6.53 Granted — — — Forfeited (39,309 ) 0.44 — Exercised (63,506 ) 0.45 — Outstanding at June 30, 2021 6,024,732 $ 0.59 6.26 Granted — — — Forfeited (10,496 ) 0.40 — Exercised (1,113,029 ) 0.44 — Outstanding at September 30, 2021 4,901,207 $ 0.62 6.80 Exercisable at September 30, 2021 4,833,059 $ 0.62 6.79 The aggregate intrinsic value in the above table is calculated as the difference between fair value of the Company’s C Stock non-vested 2021 Employee Stock Purchase Plan Upon

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 13. Fair Value Measurements Fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2021 and December 31, 2020. The carrying amounts of accounts receivable, inventory, prepaid expenses and other current assets, accounts payable, accrued expenses and other liabilities, and deferred revenue approximated fair value as they are short term in nature. The fair value of warrants issued for settlement and services are estimated based on the Black-Scholes model. The carrying value of the Company’s debt and operating lease liabilities approximated its fair value, as the obligation bears interest at rates currently available for debt with similar maturities and collateral requirements. Fair Value on a Recurring Basis The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured non-financial re-measured Description Level September 30, December 31, Liabilities: Warrant liabilities 3 $ 6,777 $ — Warrant Liabilities Prior to the Business Combination, the Company had outstanding 4,110,000 warrants C S The Private Warrants and Sponsor Warrants The Private and Sponsor Warrants are not indexed to the Company’s common shares in the manner contemplated by ASC 815-40-15 fixed-for-fixed The Company utilizes a Binomial Lattice model approach to value the Private Warrants and Sponsor Warrants at each reporting period with changes in fair value recognized in the statement of operations. The estimated fair value of the warrant liabilities is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its Common Stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon The significant unobservable inputs used in the Binomial Lattice Model to measure the warrant liabilities that are categorized within Level 3 of the fair value hierarchy are as follows: September 30, At Closing Stock price on valuation date $ 7.70 $ 8.54 Exercise price per share $ 11.50 $ 11.50 Expected life 5 years 5 years Volatility 34.8 % 43.9 % Risk-free rate 1.0 % 1.0 % Dividend yield — % — % Fair value per warrant $ 1.47 $ 2.57 The following table provides a summary of changes in fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Warrant Balance at December 31, 2020 $ — Additions pursuant to Merger 11,865 Change in fair value (5,088 ) Balance at September 30, 2021 $ 6,777 As of September 30, 2021, 4,110,000 Private Warrants and 500,000 Sponsor Warrants remain outstanding, respectively. Fair Value on a Non-Recurring The fair value of the Earnout Shares has been estimated using the trading price of our C S paid-in paid-in

Significant Concentrations

Significant Concentrations	9 Months Ended
	Sep. 30, 2021
Risks and Uncertainties [Abstract]
Significant Concentrations	Note 14. Significant Concentrations One customer accounted for approximately 22% and 23% of revenue for the three months ended September 30, 2021 and 2020, respectively. No other customers represented more than 10% of revenue for the three months ended September 30, 2021 and 2020. One customer accounted for approximately 23% and 22% of revenue for the nine months ended September 30, 2021 and 2020, respectively. No other customers represented more than 10% of revenue for the nine months ended September 30, 2021 and 2020. One vendor accounted for approximately 15% of purchases for the nine months ended September 30, 2021. No other vendors represented more than 10% of purchases for the nine months ended September 30, 2021 and 2020. As of September 30, 2021 and December 31, 2020, one customer accounted for approximately 55% and 32% of accounts receivable, respectively. No other customers represented more than 10% of outstanding accounts receivable as of September 30, 2021 and December 31, 2020. As of September 30, 2021, four vendors accounted for approximately 19%, 12%, 12%, and 11% of accounts payable. As of December 31, 2020, five vendors accounted for approximately 18%, 15%, 15%, 11% and 10% of accounts payable. No other vendors represented more than 10% of outstanding accounts payable balance as of September 30, 2021 and December 31, 2020.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 15. Related Party Transactions During 2012, the Company signed a $175 promissory note (the “Related Party Note”) with an officer of the Company, bearing interest equal to the greater of (a) 0.88% per annum or (b) the mid-term C S

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 16. Subsequent Events The Company has evaluated all known subsequent events through November 15, 2021, which is the date these condensed consolidated financial statements were available to be issued, and has determined that no subsequent events have occurred requiring recognition or disclosure in these condensed consolidated financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information as defined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and in accordance with the instruction to Form 10-Q S-X The Business Combination has been accounted for as a reverse recapitalization, in accordance with U.S. GAAP (the “Reverse Recapitalization”). Under this method of accounting, Galileo has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination has been treated as the equivalent of Legacy Shapeways issuing stock for the net assets of Galileo, accompanied by a recapitalization. The net assets of Galileo are stated at historical cost, with no goodwill or other intangible assets recorded. There has been no accounting effect or change in the carrying amount of the assets and liabilities as a result of the Business Combination. Legacy Shapeways has been treated as the accounting acquirer based on evaluation of the following facts and circumstances with regard to the Company as of the Closing: • Legacy Shapeways’ directors represented the majority of the new board of directors of the Company; • The executive officers and senior management of Legacy Shapeways are the executive officers and senior management of the Company; • The assets of Legacy Shapeways represent a significant majority of the assets of the Company (excluding cash formerly held in the Galileo trust account); and • The business of the Company will be the continued business of Legacy Shapeways. The business of the Company will continue to focus on Legacy Shapeways’ core offerings related to the facilitation of the sale, design and manufacturing of 3D printed items. The consolidated assets, liabilities and results of operations prior to the Reverse Recapitalization are those of Legacy Shapeways. The shares and corresponding capital amounts and losses per share, prior to the Merger, have been retroactively adjusted based on shares reflecting the conversion ratio (as defined below) established in the Merger.
Use of Estimates	Use of Estimates The preparation of the Company’s unaudited In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19)
Functional Currency	Functional Currency The local currency is the functional currency for Shapeways BV’s (a wholly
Cash, Cash Equivalents and Restricted Cash	Cash, Cash Equivalents and Cash includes cash on hand and demand deposits. The Company maintains its deposits at high quality financial institutions and monitors the credit ratings of those institutions. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. While cash held by financial institutions may at times exceed federally insured limits The reconciliation of cash, cash equivalents and restricted cash reported within the applicable consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statements of cash flows is as follows: September 30, 2021 December 31, 2020 Cash and cash equivalents $ 90,108 $ 8,564 Restricted cash 143 145 $ 90,251 $ 8,709
Accounts Receivable	Accounts Receivable Accounts receivables are recorded at the invoiced amount and are generally unsecured as they are uncollateralized. The Company provides an allowance for doubtful accounts to reduce receivables to their estimated net realizable value. Judgement is exercised in establishing allowances and estimates are based on the customers’ payment history and liquidity. Any amounts that were previously recognized as revenue and subsequently determined to be uncollectible are charged to bad debt expense included in selling, general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive loss. Given the nature and historical collectability of the Company’s accounts receivable, an allowance for doubtful accounts was not deemed necessary at September 30, 2021 and December 31, 2020.
Inventory	Inventory Inventory consists of raw materials, work in progress and finished goods at the Company’s distribution center. Raw materials are stated at the lower of cost or net realizable value, determined by the first-in-first-out
Property and Equipment, net	Property and Equipment, net Property and equipment are stated at cost, less accumulated depreciation. Maintenance and repairs are charged to expense when incurred. Additions and improvements that extend the economic useful life of the asset are capitalized and depreciated over the remaining useful lives of the assets. The cost and accumulated depreciation of assets sold or retired are removed from the respective accounts, and any resulting gain or loss is reflected in current earnings. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020. Depreciation is recognized using the straight-line method in amounts considered to be sufficient to allocate the cost of the assets to operations over the estimated useful lives or lease terms, as follows: Asset Category Depreciable Life Machinery and equipment 5 years Computers and IT equipment 3 years Furniture and fixtures 7 years Leasehold improvements * * ** Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life of the asset.
Long-Lived Assets, Including Definite-Lived Intangible Assets	Long-Lived Assets, Including Definite-Lived Intangible Assets Intangible assets, which consist of technology, customer relationships, and trademarks, are stated at cost less accumulated amortization. Amortization is generally recorded on a straight-line basis over estimated useful lives ranging from three to eight years. The Company periodically reviews the estimated useful lives of intangible assets and adjusts when events indicate that a shorter life is appropriate. In accordance with authoritative accounting guidance, capitalization of costs to develop software begin when preliminary development efforts are successfully and completed. Costs related to the design or maintenance of internal-use Long-lived assets, other than goodwill and other indefinite-lived intangibles, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable through the estimated undiscounted future cash flows derived from such assets. Factors that the Company considers in deciding when to perform an impairment review include significant changes in the Company’s forecasted projections for the asset or asset group for reasons including, but not limited to, significant underperformance of a product in relation to expectations, significant changes, or planned changes in the Company’s use of the assets, significant negative industry or economic trends, and new or competing products that enter the marketplace. The impairment test is based on a comparison of the undiscounted cash flows expected to be generated from the use of the asset group. If impairment is indicated, the asset is written down by the amount by which the carrying value of the asset exceeds the related fair value of the asset with the related impairment charge recognized within the statements of operations and comprehensive loss. No impairment charges were recorded for the periods ended September 30, 2021 and December 31, 2020.
Goodwill	Goodwill Goodwill, which represents the excess of purchase prices over the fair value of net assets acquired, is carried at cost. Goodwill is not amortized; rather, it is subject to a periodic assessment for impairment by applying a fair value-based test. Goodwill is evaluated for impairment on an annual basis at a level of reporting referred to as the reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. Under ASC 350, Intangibles - Goodwill and Other the fair value of a reporting unit is less than its carrying amount, then the goodwill impairment test is performed. Impairment tests are performed, at a minimum, in the fourth quarter of each year. Management uses the future discounted cash flows valuation approach to determine the fair value of reporting units and determines whether the fair value of reporting units exceeded its carrying amounts. If the fair value exceeds the carrying amount, then no impairment is recognized. If the carrying amount recorded exceeds the fair value calculated, then an impairment charge is recognized for the difference. The impairment review requires management to make judgments in determining various assumptions with respect to revenues, operating margins, growth rates and discount rates. The judgments made in determining the projected cash flows used to estimate the fair value can materially impact the Company’s financial condition and results of operations. There was no impairment of goodwill as of September 30, 2021 or December 31, 2020
Fair Value Measurements	Fair Value Measurements The Company applies ASC 820, Fair Value Measurement The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below: Level 1 - Level 2 - Level 3 -
Revenue Recognition	Revenue Recognition Revenue is derived from two primary sources: a) products and services and b) software. The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the products or services it transfers to the customer. These contracts have different terms based on the scope, performance obligations, and complexity of the project, which often requires us to make judgments and estimates in recognizing revenues. Performance obligations are satisfied both at a point
Leases	Leases The Company’s lease arrangements relate primarily to office and manufacturing space, and equipment. The Company’s leases generally have initial terms ranging from 5 to 10 years and may include renewal options and rent escalation clauses. The Company is typically required to make fixed minimum rent payments relating to its right to use an underlying leased asset. Additionally, the Company’s leases do not contain significantly restrictive covenants or residual value guarantees. The Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented as right-of-use arrangements. ROU assets represent the Company’s right to use an underlying asset, and lease liabilities represent the Company’s obligation for lease payments in exchange for the ability to use the asset for the duration of the lease term. The Company does not recognize short term leases that have a term of twelve months or less as ROU assets or lease liabilities. The Company’s short-term leases are not material and do not have a material impact on its ROU assets or lease liabilities. ROU assets and lease liabilities The Company has lease agreements which contain both lease and non-lease non-lease
Stock-based Compensation	Stock-based Compensation The Company recognizes stock-based compensation expense for all options and other arrangements within the scope of ASC 718, Stock Compensation
Public and Private Common Stock Warrant Liabilities	Public and Private Common Stock Warrant Liabilities As part of Galileo’s initial public offering, Galileo issued to third party investors 13,800,000 units, consisting of one ordinary share of Galileo and one warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of C S The Private Warrants are identical The Company evaluated the Public and Private Warrants under ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity 815-40”),
Research and Development Costs	Research and Development Costs Research and development expenses consist primarily of allocated personnel costs, fees paid to consultants and outside service providers, and allocations for rent and overhead. Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received. For the three months ended September 30, 2021 and 2020, research and development costs were $1,673 and $1,516, respectively. For the nine months ended September 30, 2021 and 2020, research and development costs were $4,099 and $4,289, respectively.
Advertising	Advertising Advertising costs are expensed as incurred. For the three months ended September 30, 2021 and 2020, advertising costs were $568 and $123, respectively. For the nine months ended September 30, 2021 and 2020, advertising costs were $1,008 and $353, respectively, which are included in selling, general and administrative expense on the condensed
Income Taxes	Income Taxes The Company files income tax returns in the The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on income tax returns it files if such tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. These tax benefits are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution. Although the Company believes that i t In applying the estimated annual effective tax rate approach prescribed under ASC 740, Income Taxes, (1.78)% for the nine months ended September 30, 2021 differs from the applicable statutory tax rate primarily due to the fact that income recognized for the forgiveness of loans granted under the PPP loan program and changes in the fair value of warrant liabilities are not taxable under current U.S. tax law.
Income (Loss) per Share	Income (Loss) per Share In accordance with the provisions of ASC 260, Earnings Per Share if-converted The following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Common stock warrants 18,410,000 — 18,410,000 — Earnout Shares 3,510,405 — 3,510,405 — Included in income (loss) per common share are options
Segment Information	Segment Information The Company has determined that it operates and reports in one segment, which focuses on providing additive manufacturing services to customers. The Company’s operating segment is reported in a manner consistent with the internal reporting provided to the chief operating decision maker (“CODM”). The Company’s CODM has been identified as its Chief Executive Officer.
Recent Accounting Standards	Recent Accounting Pronouncements Accounting Pronouncements Recently Adopted In January 2017, the FASB issued Accounting Standard Update (“ASU”) No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, 2017-04 In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes No. 2019-12 No. 2019-12 No. 2019-12 2019-12 In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) 815-40): 470-20, 2020-06 In August 2018, the FASB issued ASU No. 2018-15, Intangibles – Goodwill and Other – Internal-Use 350-40): internal-use internal-use Accounting Pronouncements Not Yet Adopted In June 2016, the FASB issued ASU No. 2016-13, Accounting for Credit Losses (Topic 326), which requires the use of an “expected loss” model on certain types of financial instruments. The standard also amends the impairment model for available-for-sale debt securities and requires estimated credit losses to be recorded as allowances instead of reductions to amortized cost of the securities. Update No. 2016-13 is effective for annual periods beginning after December 15, 2022, including interim periods within those annual periods. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact the standard will have on its condensed consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2021
Summary of Significant Accounting Policies
Summary Of Reconciliation Of Cash And Cash Equivalents	The reconciliation of cash, cash equivalents and restricted cash reported within the applicable consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statements of cash flows is as follows: September 30, 2021 December 31, 2020 Cash and cash equivalents $ 90,108 $ 8,564 Restricted cash 143 145 $ 90,251 $ 8,709
Summary Of Useful Lives Of Property Plant And Equipment	Asset Category Depreciable Life Machinery and equipment 5 years Computers and IT equipment 3 years Furniture and fixtures 7 years Leasehold improvements * *
Summary Of Common Stock equivalents Outstanding Were Excluded From Computation Of Diluted Net Loss Per Share	The following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Common stock warrants 18,410,000 — 18,410,000 — Earnout Shares 3,510,405 — 3,510,405 —

Reverse Recapitalization (Table

Reverse Recapitalization (Tables)	9 Months Ended
	Sep. 30, 2021
Reverse Recapitalization [Abstract]
Schedule Of Common Stock Shares Issued Following The Consummation Of Merger	The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of cash flows for the nine months ended September 30, 2021: Recapitalization Cash - Galileo trust and cash, net of redemption $ 28,115 Cash - PIPE Investment, net of transaction costs 75,000 Less: transaction costs and advisory fees allocated to equity (16,323 ) Effect of Merger, net of redemption, transaction costs and advisory costs $ 86,792
Schedule of reconciles the elements of business combination to the unaudited consolidated statement of changes in stockholders equity	The following table reconciles the elements of the Business Combination to the unaudited condensed consolidated statement of changes in stockholders’ equity (deficit) for the three and nine months ended September 30, 2021: Recapitalization Cash - Galileo trust and cash, net of redemption $ 28,115 Non-cash 46 Less: fair value of Private and Sponsor Warrant liabilities (11,865 ) Less: transaction costs and advisory fees allocated to equity (6,260 ) Effect of Merger, net of redemption, transaction costs and advisory costs $ 10,036
Schedule Of Common Stock Shares Issued Following The Consummation Of Business Combination	The following table details the number of shares of Common Stock issued immediately following the consummation of the Business Combination: Number of Shares Common stock, outstanding prior to Business Combination 13,800,000 Less: redemption of Galileo shares (11,018,352 ) Common stock of Galileo 2,781,648 Galileo founder and representative shares, net of forfeited shares 2,910,000 Shares issued in PIPE Investment 7,500,000 Merger and PIPE Investment - common stock 13,191,648 Legacy Shapeways shares - common stock (1) 35,104,836 Total shares of common stock immediately after Business Combination 48,296,484 (1) Includes 3,510,405 Earnout Shares

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2021
Revenue from Contract with Customer [Abstract]
Summary of amount disaggregated by revenue	Three Months Ended Nine Months Ended 2021 2020 2021 2020 Major products/service lines: Direct sales $ 5,985 $ 5,994 $ 19,068 $ 16,827 Marketplace sales 1,663 2,091 6,062 6,060 Software 68 22 224 141 Total revenue $ 7,716 $ 8,107 $ 25,354 $ 23,028 Timing of revenue recognition: Products transferred at a point in time $ 1,663 $ 2,091 $ 6,062 $ 6,060 Products and services transferred over time 6,053 6,016 19,292 16,968 Total revenue $ 7,716 $ 8,107 $ 25,354 $ 23,028
Summary of deferred revenue activity	Deferred Revenue Balance at January 1, 2021 $ 753 Deferred revenue recognized during period (25,354 ) Additions to deferred revenue during period 25,259 Balance at September 30, 2021 $ 658

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Sep. 30, 2021
Inventory Disclosure [Abstract]
Summary of components of inventory	September 30, December 31, Raw materials $ 418 $ 521 Work-in-process 40 36 Finished goods 115 170 Total $ 573 $ 727

Prepaid Expenses and Other Cu_2

Prepaid Expenses and Other Current Assets (Tables)	9 Months Ended
	Sep. 30, 2021
Prepaid Expense and Other Assets, Current [Abstract]
Summary of prepaid expenses and other current assets	September 30, December 31, Prepaid expenses $ 698 $ 646 Security deposits 259 259 VAT receivable 950 975 Other current assets 1 30 Total $ 1,908 $ 1,910

Property and Equipment, net (Ta

Property and Equipment, net (Tables)	9 Months Ended
	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Summary of property and equipment	September 30, December 31, Machinery and equipment $ 1,388 $ 1,430 Computers and IT equipment 5,631 5,193 Furniture and fixtures 49 50 Leasehold improvements 2,477 2,520 9,545 9,193 Less: Accumulated depreciation (8,455 ) (8,245 ) Property and equipment, net $ 1,090 $ 948

Accrued Expenses and Other Li_2

Accrued Expenses and Other Liabilities (Tables)	9 Months Ended
	Sep. 30, 2021
Accrued Expenses And Other Liabilities Current [Abstract]
Summary of accrued expenses and other liabilities	September 30, December 31, Accrued selling expenses $ 712 $ 947 Accrued compensation 757 876 Interest payable — 612 Taxes payable 306 477 Accrued transaction costs 450 — Accrued acquisition of property and equipment 441 — Shapeways credits 300 313 Other 734 94 Total $ 3,700 $ 3,319

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Summary of certain information related to the lease costs	Three Months Ended Nine Months Ended 2021 2020 2021 2020 Operating lease expense $ 144 $ 482 $ 696 $ 1,585 Finance lease expense — — — 16 Interest expense on finance lease liabilities — — — 1 Short-term lease expense — — — 14 Total lease cost $ 144 $ 482 $ 696 $ 1,616
Summary of right of use assets and lease liabilities for operating leases	September 30, December 31, Assets: Right-of-use $ 982 $ 2,102 Total lease assets $ 982 $ 2,102 Liabilities: Current liabilities: Operating lease liabilities, current $ 631 $ 1,222 Non-current Operating lease liabilities, net of current portion 499 $ 1,094 Total lease liability $ 1,130 $ 2,316
Summary of supplemental cash flow information related to the Company's leases	Nine Months Ended 2021 2020 Operating cash flows from operating leases $ 762 $ 1,754 Operating cash flows from finance leases — 1 Financing cash flows from finance leases — 18 Lease liabilities arising from obtaining right-of-use — 4,025
Summary of future minimum lease payments required under operating leases	Rest of 2021 $ 167 2022 680 2023 214 2024 132 2025 1 Total minimum lease payments 1,194 Less effects of discounting (64 ) Present value of future minimum lease payments $ 1,130

Borrowing Arrangements (Tables)

Borrowing Arrangements (Tables)	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Summary of outstanding debt obligation	The Company’s outstanding debt obligations consisted of the following: September 30, December 31, Dutch Landlord Loan $ 127 $ 163 Term Loan — 3,423 Convertible Promissory Notes — 5,000 PPP Loan — 1,982 127 10,568 Less: current portion (39 ) (8,332 ) Long-term debt $ 88 $ 2,236

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Summary of assumptions used to determine the fair value of the stock options	The assumptions used to estimate the fair value of stock options granted during the periods presented were as follows: Three and Nine Months Ended 2021 2020 Strike price $ 0.17 $ 0.37 Expected term (in years) 5.55 - 6.05 5.00 - 6.04 Expected volatility 57.09% - 57.81 % 49.15% - 52.41 % Risk-free interest rate 0.50% - 0.57 % 0.37% - 1.46 % Dividend yield — —
Summary of stock option plan and the activity	The following table summarizes the Company’s stock option plan and the activity: Shares Weighted Weighted Outstanding at January 1, 2021 (as previously reported) 8,247,340 $ 0.44 6.72 Retroactive application of reverse recapitalization (1,967,440 ) — — Outstanding as of January 1, 2021, effect of Merger 6,279,900 $ 0.58 6.64 Granted 29,420 0.36 9.82 Forfeited (145,878 ) 0.43 — Exercised (35,895 ) 0.43 — Outstanding at March 31, 2021 6,127,547 $ 0.58 6.53 Granted — — — Forfeited (39,309 ) 0.44 — Exercised (63,506 ) 0.45 — Outstanding at June 30, 2021 6,024,732 $ 0.59 6.26 Granted — — — Forfeited (10,496 ) 0.40 — Exercised (1,113,029 ) 0.44 — Outstanding at September 30, 2021 4,901,207 $ 0.62 6.80 Exercisable at September 30, 2021 4,833,059 $ 0.62 6.79

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of assets and liabilities that are measured at fair value on a recurring basis	The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, December 31, Liabilities: Warrant liabilities 3 $ 6,777 $ —
Schedule of key inputs	The significant unobservable inputs used in the Binomial Lattice Model to measure the warrant liabilities that are categorized within Level 3 of the fair value hierarchy are as follows: September 30, At Closing Stock price on valuation date $ 7.70 $ 8.54 Exercise price per share $ 11.50 $ 11.50 Expected life 5 years 5 years Volatility 34.8 % 43.9 % Risk-free rate 1.0 % 1.0 % Dividend yield — % — % Fair value per warrant $ 1.47 $ 2.57
Schedule of changes in the fair value of warrant liabilities	The following table provides a summary of changes in fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Warrant Balance at December 31, 2020 $ — Additions pursuant to Merger 11,865 Change in fair value (5,088 ) Balance at September 30, 2021 $ 6,777

Organization (Details)

Organization (Details) - Shapeways Inc [Member] Supplychainpartners in Millions, Customers in Millions	9 Months Ended
	Sep. 30, 2021CountriesAdditivetechnolgiesSupplychainpartnersCustomersMaterialsandfinishes
Subsidiary, Sale of Stock [Line Items]
Number of manufacturing parts delivered | Supplychainpartners	21
Number of customers | Customers	1
Number of countries | Countries	160
Number of utilization of additive technologies | Additivetechnolgies	11
Minimum [Member]
Subsidiary, Sale of Stock [Line Items]
Number of materials and finishes | Materialsandfinishes	90

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Thousands	Oct. 22, 2019	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Financing Receivable, Impaired [Line Items]
Asset impairment charges				$ 0		$ 0
Goodwill impairment loss				0		$ 0
Research and development expense		$ 1,673	$ 1,516	4,099	$ 4,289
Advertising expense		$ 568	$ 123	$ 1,008	$ 353
Percentage of largest benefit greater than likelyhood of resolution for tax benefit measurement				50.00%
Effective income tax reconciliation rate				1.78%
Weighted average shares included in computation of earning per share				4,833,059		3,673,963
Tangible asset impairment charges				$ 0		$ 0
IPO [Member]
Financing Receivable, Impaired [Line Items]
Stock issued during period new shares issued	13,800,000
Sale of stock price per share	$ 10
Warrants exercise price per share	$ 11.50
Private Placement [Member] | Private Warrants [Member]
Financing Receivable, Impaired [Line Items]
Stock issued during period new shares issued	4,110,000
Warrants exercise price per share	$ 1
Convesrion of promissory note, warrants issued	500,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of reconciliation of cash and cash equivalents (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 90,108	$ 8,564
Restricted cash	143	145
Total	$ 90,251	$ 8,709

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary of useful lives of property plant and equipment (Details)	9 Months Ended
	Sep. 30, 2021
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Computers and IT equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	7 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	0 years

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Sep. 30, 2020
Equity [Abstract]
Common stock warrants	$ 18,410,000	$ 0
Earnout Shares	$ 3,510,405	$ 0

Reverse Recapitalization - Sche

Reverse Recapitalization - Schedule of common stock shares issued following the consummation of merger (Details) - Reverse Recapitalization [Member] - Business Combination Elements To Unaudited consolidated Statement Of Cash Flows [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)
Schedule Of Reconciliation Of Elements Of The business Combination To The Unaudited Consolidated Of Cash Flows [Line Items]
Less: transaction costs and advisory fees allocated to equity	$ (16,323)
Effect of Merger, net of redemption, transaction costs and advisory costs	86,792
PIPE Investment [Member]
Schedule Of Reconciliation Of Elements Of The business Combination To The Unaudited Consolidated Of Cash Flows [Line Items]
Payments to Acquire Businesses, Gross	75,000
Galileo [Member]
Schedule Of Reconciliation Of Elements Of The business Combination To The Unaudited Consolidated Of Cash Flows [Line Items]
Payments to Acquire Businesses, Gross	$ 28,115

Reverse Recapitalization - Sc_2

Reverse Recapitalization - Schedule of reconciles the elements of business combination to the unaudited consolidated statement of changes in stockholders equity (Details) - Reverse Recapitalization [Member] - Business Combination Elements To Unaudited consolidated Statement Of Equity [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)
Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity [Line Items]
Cash - Galileo trust and cash, net of redemption	$ 28,115
Less: transaction costs and advisory fees allocated to equity	(6,260)
Effect of Merger, net of redemption, transaction costs and advisory costs	10,036
Private Sponsor Warrant Liabilities [Member]
Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity [Line Items]
Less: fair value of Private and Sponsor Warrant liabilities	(11,865)
Galileo [Member]
Schedule Of Reconciliation Of Elements Of Business Combination to Changes In Stockholders Equity [Line Items]
Non-cash net working capital assumed from Galileo	$ 46

Reverse Recapitalization - Sc_3

Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Details)	9 Months Ended
	Sep. 30, 2021shares
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]
Beginning Balance (in Shares)	32,170,068
Ending Balance (in shares)	48,296,484
Common Stock [Member]
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]
Beginning Balance (in Shares)	32,184,263
Ending Balance (in shares)	48,296,484
Reverse Recapitalization [Member] | PIPE Investment [Member]
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]
Stock issued during period new shares issued	7,500,000
Reverse Recapitalization [Member] | Founder and Representative Shares [Member]
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]
Stock issued during period new shares issued	2,910,000
Reverse Recapitalization [Member] | Common Stock [Member] | Merger And Investment [Member]
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]
Stock issued during period new shares issued	13,191,648
Reverse Recapitalization [Member] | Common Stock [Member] | Immediately After Business Combination [Member]
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]
Ending Balance (in shares)	48,296,484
Reverse Recapitalization [Member] | Galileo [Member]
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]
Less: redemption of Galileo shares	(11,018,352)
Reverse Recapitalization [Member] | Galileo [Member] | Common Stock [Member]
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]
Stock issued during period new shares issued	2,781,648
Reverse Recapitalization [Member] | Shapeways Inc [Member] | Common Stock [Member]
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]
Stock issued during period new shares issued	35,104,836
Reverse Recapitalization [Member] | Prior to business combination [Member] | Common Stock [Member]
Disclosure Of Common Stock Shares Issued Following The Consummation Of Business Combination [Line Items]
Beginning Balance (in Shares)	13,800,000

Reverse Recapitalization - Sc_4

Reverse Recapitalization - Schedule of common stock shares issued following the consummation of business combination (Parenthetical) (Details)	Sep. 30, 2021shares
Reverse Recapitalization [Abstract]
Earnout shares	3,510,405

Reverse Recapitalization (Detai

Reverse Recapitalization (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2021	Sep. 29, 2021	Sep. 30, 2021	Dec. 31, 2020
Reverse Recapitalization [Line Items]
Common stock, par value	$ 0.0001		$ 0.0001	$ 0.0001
Reverse Recapitalization [Member]
Reverse Recapitalization [Line Items]
Conversion of preferred and common stock issued upon exercise of warrants converted into aggregate number of shares of common stock		301,750
Number of consecutive trading days to determine the trading price per share	30 days
Reverse Recapitalization [Member] | Pipe Investors [Member] | Subscription Agreement [Member]
Reverse Recapitalization [Line Items]
Stock issued during period new shares issued			7,500,000
Purchase price per share	$ 10		$ 10
Shared issued value			$ 75,000,000
Reverse Recapitalization [Member] | Trading Price One [Member]
Reverse Recapitalization [Line Items]
Volume weighted average trading price of common stock	14		$ 14
Reverse Recapitalization [Member] | Trading Price Two [Member]
Reverse Recapitalization [Line Items]
Volume weighted average trading price of common stock	$ 16		$ 16
Earnout Restricted Stock Units [Member] | Reverse Recapitalization [Member]
Reverse Recapitalization [Line Items]
Number of restricted stock units granted		493,489
Two Thousand Twenty One Equity Incentive Plan [Member] | Reverse Recapitalization [Member]
Reverse Recapitalization [Line Items]
Conversion of stock in to Aggregate number of options to purchase		4,901,207
Shapeways Inc [Member] | Reverse Recapitalization [Member] | Galileo [Member]
Reverse Recapitalization [Line Items]
Aggregate merger consideration value		$ 406,000
Common Stock [Member] | Shapeways Inc [Member] | Reverse Recapitalization [Member]
Reverse Recapitalization [Line Items]
Conversion of stock shares issued		35,104,836
Common stock, par value		$ 0.0001
Stock issued during period new shares issued			35,104,836
Earnout Shares [Member] | Reverse Recapitalization [Member]
Reverse Recapitalization [Line Items]
Conversion of stock shares issued		3,510,405
Earnout Shares [Member] | Reverse Recapitalization [Member] | Galileo [Member]
Reverse Recapitalization [Line Items]
Number of shares issued as merger consideration			3,510,405

Revenue Recognition - Marketpla

Revenue Recognition - Marketplace sales (Details)	9 Months Ended
	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Percentage of markup fee upon the sale of products through the marketplace	3.50%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of revenues (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Total revenue	$ 7,716	$ 8,107	$ 25,354	$ 23,028
Direct sales
Disaggregation of Revenue [Line Items]
Total revenue	5,985	5,994	19,068	16,827
Marketplace sales
Disaggregation of Revenue [Line Items]
Total revenue	1,663	2,091	6,062	6,060
Software
Disaggregation of Revenue [Line Items]
Total revenue	68	22	224	141
Products transferred at a point in time
Disaggregation of Revenue [Line Items]
Total revenue	1,663	2,091	6,062	6,060
Products and services transferred over time
Disaggregation of Revenue [Line Items]
Total revenue	$ 6,053	$ 6,016	$ 19,292	$ 16,968

Revenue Recognition - Deferred

Revenue Recognition - Deferred revenues (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Jan. 01, 2020
Revenue from Contract with Customer [Abstract]
Deferred revenue at beginning of period	$ 753
Deferred revenue recognized during period	(25,354)
Additions to deferred revenue during period	25,259
Deferred revenue at end of period	658
Deferred revenue recognized	753
Accounts receivable	$ 1,114	$ 185	$ 151

Revenue Recognition - Practical

Revenue Recognition - Practical expedients and exemptions (Details)	9 Months Ended
	Sep. 30, 2021
Revenue from Contract with Customer [Abstract]
Practical Expedients, incremental costs of obtaining a contract	true

Inventory (Details)

Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Raw materials	$ 418	$ 521
Work-in-process	40	36
Finished goods	115	170
Total	$ 573	$ 727

Prepaid Expenses and Other Cu_3

Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Prepaid Expense and Other Assets, Current [Abstract]
Prepaid expenses	$ 698	$ 646
Security deposits	259	259
VAT receivable	950	975
Other current assets	1	30
Total	$ 1,908	$ 1,910

Property and Equipment, net (De

Property and Equipment, net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 9,545		$ 9,545		$ 9,193
Less: Accumulated depreciation	(8,455)		(8,455)		(8,245)
Property and equipment, net	1,090		1,090		948
Depreciation expense	146	$ 115	424	$ 362
Depreciation charged to cost of revenue	113	$ 78	324	$ 249
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,388		1,388		1,430
Computers and IT equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	5,631		5,631		5,193
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	49		49		50
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,477		$ 2,477		$ 2,520

Accrued Expenses and Other Li_3

Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Accrued Expenses And Other Liabilities Current [Abstract]
Accrued selling expenses	$ 712	$ 947
Accrued compensation	757	876
Interest payable		612
Taxes payable	306	477
Accrued transaction costs	450
Accrued acquisition of property and equipment	441
Shapeways credits	300	313
Other	734	94
Total	$ 3,700	$ 3,319

Commitments and Contingencies -

Commitments and Contingencies - Leases (Details) - lease	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Number of leases of facilities located in the United States and the Netherlands	3
Number of leases of office equipment, under operating leases	1
Number of additional lease of equipment under a finance lease arrangement		1

Commitments and Contingencies_2

Commitments and Contingencies - Company's lease costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Lease, Cost [Abstract]
Operating lease expense	$ 144	$ 482	$ 696	$ 1,585
Finance lease expense				16
Interest expense on finance lease liabilities				1
Short-term lease expense				14
Total lease cost	$ 144	$ 482	$ 696	$ 1,616

Commitments and Contingencies_3

Commitments and Contingencies - Right of use assets and lease liabilities for operating leases (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Assets:
Right-of-use assets, net	$ 982	$ 2,102
Total lease assets	982	2,102
Liabilities:
Operating lease liabilities, current	631	1,222
Non-current liabilities: Operating lease liabilities, net of current portion	499	1,094
Total lease liability	$ 1,130	$ 2,316

Commitments and Contingencies_4

Commitments and Contingencies - Weighted-average (Details)	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Weighted-average remaining lease term for operating leases	2 years 18 days
Weighted-average incremental borrowing rate	5.34%

Commitments and Contingencies_5

Commitments and Contingencies - Supplemental cash flow (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Summary Of Leases Supplemental Cash Flow Information [Abstract]
Operating cash flows from operating leases	$ 762	$ 1,754
Operating cash flows from finance leases		1
Financing cash flows from finance leases		18
Lease liabilities arising from obtaining right-of-use assets		$ 4,025

Commitments and Contingencies_6

Commitments and Contingencies - Future minimum lease payments (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
Rest of 2021	$ 167
2022	680
2023	214
2024	132
2025	1
Total minimum lease payments	1,194
Less effects of discounting	(64)
Present value of future minimum lease payments	$ 1,130	$ 2,316

Commitments and Contingencies_7

Commitments and Contingencies - Additional Information (Details) - Desktop Metal [Member] - USD ($) $ in Millions	Mar. 26, 2021	Nov. 30, 2021	Dec. 31, 2021
Other Commitments [Line Items]
Long-term Purchase Commitment, Amount	$ 20
Purchase obligation	$ 20
Subsequent Event [Member]
Other Commitments [Line Items]
Payments to Acquire desktop metal		$ 3.5
Property purchase payable			$ 16.5

Borrowing Arrangements - Term L

Borrowing Arrangements - Term Loan (Details) - Term Loan [Member] - USD ($) $ in Thousands	Oct. 29, 2018	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Debt Instrument [Line Items]
Aggregate principal amount	$ 5,000
Interest rate						3.50%
Fee in the event of liquidity event		$ 75		$ 75
Interest expense		$ 12	$ 36	$ 66	$ 129
Prime Rate [Member]
Debt Instrument [Line Items]
Spread on variable rate	0.25%

Borrowing Arrangements - Dutch

Borrowing Arrangements - Dutch landlord loan (Details) - Dutch Landlord Loan [Member] € in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Dec. 31, 2020USD ($)	May 12, 2014EUR (€)
Debt Instrument [Line Items]
Aggregate principal amount	$ 280		$ 280		$ 297	€ 242
Interest rate	8.50%		8.50%		8.50%
Interest expense	$ 5	$ 5	$ 14	$ 14

Borrowing Arrangements - Outsta

Borrowing Arrangements - Outstanding debt obligations (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Long-term debt, including current portion	$ 127	$ 10,568
Less: current portion	(39)	(8,332)
Long-term debt	88	2,236
Dutch Landlord Loan
Debt Instrument [Line Items]
Long-term debt, including current portion	127	163
Term Loan
Debt Instrument [Line Items]
Long-term debt, including current portion	0	3,423
Convertible Promissory Notes
Debt Instrument [Line Items]
Long-term debt, including current portion	0	5,000
PPP Loan
Debt Instrument [Line Items]
Long-term debt, including current portion	$ 0	$ 1,982

Borrowing Arrangements - Conver

Borrowing Arrangements - Convertible promissory notes (Details) - USD ($) $ in Thousands	Sep. 29, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 19, 2019
Debt Instrument [Line Items]
Common Stock, Shares, Outstanding		48,296,484		48,296,484		32,170,068
Legacy Shapeways [Member] | Post Business Combination [Member]
Debt Instrument [Line Items]
Common Stock, Shares, Outstanding		1,189,558		1,189,558
Legacy Shapeways [Member] | Unpaid And Accrued Interest [Member] | Post Business Combination [Member]
Debt Instrument [Line Items]
Common Stock, Shares, Outstanding		217,183		217,183
Common Stock [Member]
Debt Instrument [Line Items]
Common Stock, Shares, Outstanding		48,296,484	32,132,078	48,296,484	32,132,078	32,184,263	32,302,841	32,220,158	32,063,523	31,922,253	31,921,259
Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Aggregate principal amount												$ 5,000
Interest rate												8.00%
Conversion price defined as percentage of next equity price per share						70.00%
Interest expense		$ 109	$ 100	$ 309	$ 300
Debt conversion convertible instrument amount	$ 5,000
Debt instrument unpaid and accrued interest		$ 913		$ 913
Convertible Notes Payable [Member] | Common Stock [Member]
Debt Instrument [Line Items]
Debt conversion converted instrument shares issued	1,434,391
Convertible Notes Payable [Member] | Common Stock [Member] | Unpaid And Accrued Interest [Member]
Debt Instrument [Line Items]
Debt conversion converted instrument shares issued	261,884

Borrowing Arrangements - Payche

Borrowing Arrangements - Paycheck protection program loan (Details) - PPP Loan - USD ($) $ in Thousands	May 04, 2020	Sep. 30, 2021	Sep. 30, 2020
Debt Instrument [Line Items]
Amount of loan received	$ 1,982
Accrues interest at annual rate	1.00%
Interest expense			$ 0
Percentage of loan amount is used for eligible payroll costs used to determine the loan proceeds eligible for forgiveness		75.00%
Other Income [Member]
Debt Instrument [Line Items]
Principal and interest amount of loan forgiven		$ 2,000
Shapeways Inc [Member]
Debt Instrument [Line Items]
Interest expense		$ 18

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Details)	Sep. 30, 2021$ / sharesshares	Sep. 29, 2021shares	May 10, 2021$ / sharesshares	Jun. 30, 2017$ / sharesshares	Apr. 22, 2015$ / sharesshares	Feb. 03, 2014$ / sharesshares	Dec. 18, 2013$ / sharesshares	Mar. 08, 2013$ / sharesshares	Sep. 30, 2021Day$ / sharesshares	Dec. 31, 2020$ / sharesshares
Class of Stock [Line Items]
Recapitalization conversion ratio		0.8293
Common stock, shares authorized	120,000,000								120,000,000	120,000,000
Common stock, par value | $ / shares	$ 0.0001								$ 0.0001	$ 0.0001
Common stock voting rights									one vote per share
Common stock, shares issued	48,296,484								48,296,484	32,170,068
Common stock, shares outstanding	48,296,484								48,296,484	32,170,068
Warrants expiry term	5 years								5 years
Redemption price (per warrant) | $ / shares									$ 0.01
Redemption notice period									30 days
Redemption share price basis | $ / shares									$ 18
Redemption share price basis number of days | Day									20
Redemption, registration statement to be maintained | Day									30
Public Warrants [Member]
Class of Stock [Line Items]
Exercise price of warrants | $ / shares	$ 11.50								$ 11.50
Warrant outstanding	13,800,000								13,800,000
Number of shares purchased	1								1
Warrants exercisable period	30 days
Legacy Shapeways Series A-1 Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock converted in to aggregate number of shares of common stock		22,579,695
Legacy Shapeways Series A-2 Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock converted in to aggregate number of shares of common stock		22,579,695
Legacy Shapeways Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock converted in to aggregate number of shares of common stock		22,579,695
Legacy Shapeways Series B-1 Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock converted in to aggregate number of shares of common stock		22,579,695
Legacy Shapeways Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock converted in to aggregate number of shares of common stock		22,579,695
Legacy Shapeways Series D Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock converted in to aggregate number of shares of common stock		22,579,695
Legacy Shapeways Series E Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock converted in to aggregate number of shares of common stock		22,579,695
Prior to Merger [Member] | Public Warrants [Member]
Class of Stock [Line Items]
Warrant outstanding	13,800,000								13,800,000
Legacy Shapeways Common Stock Warrants [Member] | Legacy Shapeways Series B-1 Preferred Stock [Member]
Class of Stock [Line Items]
Warrants exercised for number of shares of preferred stock			23,125
Legacy Shapeways Common Stock Warrants [Member] | Executing a Loan Agreement [Member]
Class of Stock [Line Items]
Purchase of stock and warrants						248,000	40,000
Exercise price of warrants | $ / shares						$ 1.25	$ 1.25
Expiration date of warrants							Dec. 18, 2023
Expiraiton period of warrants from the original issuance date						7 years
Expiraiton period of warrants from the effective date of an initial public offering						5 years
Legacy Shapeways Common Stock Warrants [Member] | Amended Loan Agreement [Member]
Class of Stock [Line Items]
Purchase of stock and warrants					13,750
Exercise price of warrants | $ / shares					$ 1.70
Expiration date of warrants					Apr. 22, 2025
Legacy Shapeways Common Stock Warrants [Member] | Prior to the Business Combination [Member]
Class of Stock [Line Items]
Common stock, shares outstanding	212,234								212,234
Outstanding warrants exercised in aggregate of shares of common stock		255,917
Legacy Shapeways Preferred Stock Warrants [Member]
Class of Stock [Line Items]
Exercise price of warrants | $ / shares			$ 2.5946	$ 5.2584				$ 2.5946
Warrants exercisable period from the date of grant				10 years				10 years
Number of warrants exercised	57,051		23,125
Warrants exercised for number of shares of Common stock	107,580
Legacy Shapeways Preferred Stock Warrants [Member] | Legacy Shapeways Series B-1 Preferred Stock [Member]
Class of Stock [Line Items]
Purchase of stock and warrants								23,125
Legacy Shapeways Preferred Stock Warrants [Member] | Legacy Shapeways Series D Preferred Stock [Member]
Class of Stock [Line Items]
Purchase of stock and warrants				57,051

Stock-Based Compensation - Fair

Stock-Based Compensation - Fair value of stock-based compensation (Details) - $ / shares	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Price	$ 0.17	$ 0.37
Expected volatility , minimum	57.09%	49.15%
Expected volatility , maximum	57.81%	52.41%
Risk-free interest rate , mininum	0.50%	0.37%
Risk-free interest rate , maximum	0.57%	1.46%
Dividend yield	0.00%	0.00%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 years 18 days	6 years 14 days
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	5 years 6 months 18 days	5 years

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock option plan (Details) - USD ($)	3 Months Ended			9 Months Ended	12 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Shares Underlying Options
Outstanding at beginning	6,024,732	6,127,547	8,247,340	8,247,340
Retroactive application of reverse recapitalization					(1,967,440)
Granted	0	0	29,420
Forfeited	(10,496)	(39,309)	(145,878)
Exercised	(1,113,029)	(63,506)	(35,895)
Outstanding at ending	4,901,207	6,024,732	6,127,547	4,901,207	8,247,340
Exercisable	4,833,059			4,833,059
Weighted Average Exercise Price
Outstanding at beginning (in dollars per share)	$ 0.59	$ 0.58	$ 0.44	$ 0.44
Retroactive application of reverse recapitalization (in dollars per share)					$ 0
Granted (in dollars per share)	0	0	0.36
Forfeited (in dollars per share)	0.40	0.44	0.43
Exercised (in dollars per share)	0.44	0.45	0.43
Outstanding at ending (in dollars per share)	0.62	$ 0.59	$ 0.58	0.62	$ 0.44
Exercisable (in dollars per share)	$ 0.62			$ 0.62
Weighted Average Remaining Contractual Term (in years)
Outstanding (in years)	6 years 9 months 18 days	6 years 3 months 3 days	6 years 6 months 10 days		6 years 8 months 19 days
Granted (in years)			9 years 9 months 25 days
Exercisable at the end (in dollars)	$ 6,790			$ 6,790
Cumulative Effect Adjusted [Member]
Shares Underlying Options
Outstanding at beginning			6,279,900	6,279,900
Outstanding at ending					6,279,900
Weighted Average Exercise Price
Outstanding at beginning (in dollars per share)			$ 0.58	$ 0.58
Outstanding at ending (in dollars per share)					$ 0.58
Weighted Average Remaining Contractual Term (in years)
Outstanding (in years)			6 years 7 months 20 days

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands	Sep. 29, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Average exercise price per share		$ 0.62	$ 0.59	$ 0.58	$ 0.62		$ 0.44
Number of shares awarded		0	0	29,420
2010 Stock Plan [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Maximum number of shares authorized for issuance	16,942,546
Percentage of exchange ratio used to determine the number of restricted stock units granted as right to receive					10.00%
Aggregate number of options to purchase		4,901,207			4,901,207
Average exercise price per share		$ 0.62			$ 0.62
2010 Stock Plan [Member] | Legacy Shapeways Stock Option [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Percentage of recapitalization conversion ratio for conversion in to common stock	90.00%
Percentage of recapitalization conversion ratio as divider for determining exercise price	90.00%
2021 Equity Incentive Plan [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Maximum number of shares authorized for issuance		7,621,401			7,621,401
Number of shares awarded					0
Number of shares remain available for issuance		7,621,401			7,621,401
Weighted-average grant-date fair value per stock option granted					$ 0.36	$ 0.50
Unrecognized compensation expense		$ 193			$ 193
Unrecognized compensation expense expected to be recognized over the weighted average period					1 year 9 months 18 days
Number of shares available for purchase		895,721			895,721
Number of shares purchased					0

Fair Value Measurements - Initi

Fair Value Measurements - Initial measurement (Details) - Private Placement Warrants - Level 3	Sep. 30, 2021sharesyr	Sep. 29, 2021sharesyr
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	1	1
Stock price on valuation date
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	7.70	8.54
Exercise price per share
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	11.50	11.50
Expected life
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input | yr	5	5
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	34.8	43.9
Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	0	0
Fair value per warrant
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	1.47	2.57

Fair Value Measurements - Subse

Fair Value Measurements - Subsequent measurement (Details) - Level 3 $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value, Beginning period	$ 0
Additions pursuant to Merger	11,865
Change in fair value	(5,088)
Fair value, End period	$ 6,777

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020
Schedule of Held-to-maturity Securities [Line Items]
Share price	$ 0.17		$ 0.37
Earnout Shares [Member]
Schedule of Held-to-maturity Securities [Line Items]
Estimated fair value of the shares recognized as a deemed dividend	$ 18,132
Convertible Note [Member]
Schedule of Held-to-maturity Securities [Line Items]
Debt conversion convertible instrument amount	$ 500
Nonrecurring | Earnout Shares [Member]
Schedule of Held-to-maturity Securities [Line Items]
Fair value of shares estimated based on trading price of common stock	$ 7.70
Sponsor Warrants [Member]
Schedule of Held-to-maturity Securities [Line Items]
Warrant outstanding	500,000
Share price	$ 1
Sponsor Warrants [Member] | Convertible Note [Member]
Schedule of Held-to-maturity Securities [Line Items]
Debt conversion converted instrument warrants issued	500,000
Private Warrants [Member]
Schedule of Held-to-maturity Securities [Line Items]
Warrant outstanding	4,110,000
Level 3
Liabilities:
Warrant liability	$ 6,777	$ 0
Level 3 | Warrant Liability | Recurring
Liabilities:
Warrant liability	$ 6,777	$ 0

Significant Concentrations (Det

Significant Concentrations (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021Customer	Sep. 30, 2020Customer	Sep. 30, 2021CustomerVendorCustomersVendors	Sep. 30, 2020CustomerCustomersVendorsVendor	Dec. 31, 2020VendorsCustomersCustomer
Accounts Payable [Member] | Other Vendor [Member]
Concentration Risk [Line Items]
Number of major vendor accounts payable over ten percent benchmark			0
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Major Vendor [Member]
Concentration Risk [Line Items]
Concentration risk percentage			15.00%	15.00%
Number of major vendor over ten percent benchmark | Vendor			1	1
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Other Vendor [Member]
Concentration Risk [Line Items]
Number of major vendor over ten percent benchmark			0	0
Supplier Concentration Risk [Member] | Accounts Payable [Member]
Concentration Risk [Line Items]
Number of major vendor accounts payable over ten percent benchmark			4		5
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Major Vendor One [Member]
Concentration Risk [Line Items]
Concentration risk percentage			19.00%		18.00%
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Major Vendor Two [Member]
Concentration Risk [Line Items]
Concentration risk percentage			12.00%		15.00%
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Major Vendor Three [Member]
Concentration Risk [Line Items]
Concentration risk percentage			12.00%		15.00%
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Major Vendor Four [Member]
Concentration Risk [Line Items]
Concentration risk percentage			11.00%
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Other Vendor [Member]
Concentration Risk [Line Items]
Number of major vendor accounts payable over ten percent benchmark					0
Major Customer [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Concentration Risk [Line Items]
Concentration risk percentage	22.00%	23.00%	23.00%	22.00%
Number of customers over ten percent benchmark | Customer	0	0	1	1
Number of major vendor over ten percent benchmark | Customer	1	1
Major Customer [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration risk percentage			55.00%		32.00%
Number of major customers accounts receivableover ten percent benchmark | Customer			1		1
Other Customer [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Concentration Risk [Line Items]
Concentration risk percentage	10.00%	10.00%	10.00%	10.00%
Number of customers over ten percent benchmark | Customers			0	0
Other Customer [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk [Line Items]
Number of major customers accounts receivableover ten percent benchmark | Customers			0		0

Related Party Transactions (Det

Related Party Transactions (Details) - Related Party Note [Member] - Officer [Member] - USD ($) $ in Thousands	Sep. 29, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2012
Related Party Transaction [Line Items]
Debt instrument face amount				$ 175
Debt instrument interest rate stated percentage				0.88%
Debt weighted average interest rate		0.84%	0.90%
Debt instrument maturity date		Aug. 10, 2021
Merger Agreement [Member]
Related Party Transaction [Line Items]
Stock repurchased during period shares	19,226